UBRELVY 100 mg/1

UBRELVY 100 mg tablets contain ubrogepant, a medication used for acute migraine treatment. This oral tablet is designed to provide relief from migraine headaches. Ubrogepant is a selective calcitonin gene-related peptide (CGRP) receptor antagonist.

UBRELVY 100 mg tablets are primarily used for the acute treatment of migraine headaches with or without aura in adults. Ubrogepant works by blocking the activity of CGRP, a molecule involved in migraine pain. This medication is not intended for preventive use but rather for the relief of migraine symptoms once they occur.

Common effects of Ubrevly 100 mg tablets may include nausea, somnolence, and dry mouth. Some users may experience fatigue or dizziness. These effects are generally mild and temporary, but if they persist or worsen, it is advisable to consult a healthcare professional.

UBRELVY 100 mg tablets should be used with caution in individuals with a history of liver problems. It is important to follow the prescribed dosage and not exceed the recommended amount. This medication should be stored at room temperature and kept out of reach of children.

UBRELVY 100 mg tablets may interact with other medications, including strong CYP3A4 inhibitors and inducers. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol should be avoided while using this medication.